H.B. Fuller (FUL) has just posted Q2 2026 results with revenue of US$950.3 million, Basic EPS of US$1.25 and net income excluding extra items of US$67.8 million, giving investors a clear look at how the business is performing at mid year. The company has seen quarterly revenue move from US$898.1 million in Q2 2025 to US$950.3 million in Q2 2026, while Basic EPS shifted from US$0.77 to US$1.25 over the same period. This sets the stage for investors to focus on how these results feed through to margins and overall earnings quality.

See our full analysis for H.B. Fuller.

With the numbers on the table, the next step is to see how this earnings print lines up with the key narratives around H.B. Fuller, highlighting where the story is confirmed and where it might be challenged.

H.B. Fuller margins improve with higher net income

• On a trailing 12 month basis, H.B. Fuller generated US$185.7 million in net income excluding extra items, with net margin at 5.3% compared with 2.9% a year earlier.
• Analysts' consensus view highlights efforts to tighten the portfolio mix and manufacturing cost structure, and the higher net margin alongside US$3.5b in trailing 12 month revenue gives some support to that view. However, ongoing pressure in areas like the solar segment shows the margin story is not uniform across the business.
  • The consensus narrative points to a greater than 20% EBITDA margin target. The current 5.3% net margin suggests there is still a gap between where profitability sits today and where that target lies.
  • Challenges in certain segments, including a 2% decline in organic solar revenue, sit alongside the stronger trailing 12 month earnings. This means investors need to separate segment level softness from the group level margin improvement.

EPS swings and 80% earnings growth

• Basic EPS on a trailing 12 month basis came in at US$3.41, with earnings reported to have grown 80% over the last year, even though quarterly EPS has moved between US$0.24 and about US$1.25 over the last six reported quarters.
• Bulls argue that pricing gains and acquisitions can keep earnings moving forward, and the 80% trailing 12 month earnings growth alongside the Q2 2026 EPS of around US$1.25 provides some support for that bullish angle. At the same time, the earlier quarters with EPS closer to US$0.24 and US$0.38 show that earnings have not been consistently at this higher level.
  • The acquisition of ND Industries and restructuring benefits in Engineering Adhesives are cited as earnings drivers, and the move from net income excluding extra items of US$13.2 million in Q1 2025 to US$67.8 million in Q2 2026 lines up with that emphasis on bolt on growth and efficiency.
  • At the same time, five year earnings are reported to have declined about 3.4% per year, which challenges the bullish idea that the recent 80% earnings lift alone signals a durable long term trend.

For investors who want to see how this stronger EPS print stacks up against the full bullish thesis on margins, growth, and acquisitions, it is worth reading the dedicated bull case for H.B. Fuller 🐂 H.B. Fuller Bull Case.

Valuation, debt coverage and H.B. Fuller risk trade off

• H.B. Fuller trades on a P/E of about 17.9x against a DCF fair value of US$61.82 and a current share price of US$61.95, while analysts are assuming revenue growth of roughly 4.4% a year and earnings growth of about 8.6% a year with net debt at a level that is not well covered by operating cash flow.
• Bears focus on leverage and growth constraints, and the combination of debt that is not well covered by operating cash flow plus forecast growth that trails broader US market expectations adds some weight to that cautious view, even though the current P/E is below peers and the DCF fair value sits very close to the share price.
  • Critics highlight a net debt to EBITDA ratio of 3.5x, which is above H.B. Fuller’s long term target and could limit flexibility for further acquisitions or buybacks if cash generation does not improve.
  • With analysts expecting profit margins to move from 4.6% to 6.2% over several years and an analyst price target reference point of US$71.57, the current P/E discount versus chemicals peers at 25.7x looks supportive for valuation while the weaker debt coverage keeps the bearish focus on balance sheet risk in play.

If you are weighing the cautious arguments around leverage and growth against H.B. Fuller's recent profitability gains, it helps to read a focused breakdown of the bear case alongside the raw numbers 🐻 H.B. Fuller Bear Case.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for H.B. Fuller on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

If the mix of optimism and caution around H.B. Fuller feels finely balanced, take a closer look at the underlying data and decide quickly how it all stacks up beside the 4 key rewards and 1 important warning sign

See What Else Is Out There Beyond H.B. Fuller

H.B. Fuller carries higher leverage with net debt that is not well covered by operating cash flow, which leaves less room for comfort if conditions tighten.

If that balance sheet pressure feels a bit too close for comfort, compare it with companies that score better on financial strength using the solid balance sheet and fundamentals stocks screener (48 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.